Brief: Sedana Medical Gets Data Exclusivity, Market Protection For Sedaconda Until 2031

Sedana Medical AB (publ)

22/11/2023 08:10

Nov 22 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * GETS DATA EXCLUSIVITY AND MARKET PROTECTION FOR
SEDACONDA ® 
(ISOFLURANE) UNTIL 2031
    * EUROPEAN MEDICINES AGENCY'S (EMA) PAEDIATRIC COMMITTEE HAS
GIVEN
A POSITIVE DECISION REGARDING COMPLIANCE WITH THE COMPANY'S
PEDIATRIC INVESTIGATION PLAN

Source text for Eikon:  ID:nWkrtbHrw 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))